Psychedeic-Chronicle-Logo

Suggestions

  • Psychedelic News
  • DMT
  • Ketamine
  • Mescaline
  • Psilocybin
  • CEO INTERVIEWS

Psychedeic-Chronicle-Logo

Ketamine

Choose Ketamine Complete Seed Capital Raise to Expand Technology Platform Psychedeic-Chronicle-Logo-White
Psychedelic News

Choose Ketamine Complete Capital Raise to Expand Technology Platform

In a major milestone for mental health care, Austin-based Choose Your Horizon Inc., also known as Choose Ketamine, has announced the completion

February 16, 2023
Silo Pharma Initiate Toxicity Study of Ketamine Formulation for Fibromyalgia Treatment Psychedeic-Chronicle-Logo-White
Psychedelic News

Silo Pharma Initiate Toxicity Study of Ketamine Formulation for Fibromyalgia Treatment

Silo Pharma (Nasdaq: SILO), a developmental-stage psychedelic biopharmaceutical firm, announced today that it has begun a preclinical toxicity study of its novel

October 10, 2022
Revitalist Partners with Wake Network To Offer Psychedelics for Veterans Upon 300 Month over Month Growth Psychedeic-Chronicle-Logo-White
Psychedelic News

Revitalist Partners with Wake Network To Offer Psychedelics for Veterans Upon 300% Month over Month Growth

Revitalist Lifestyle and Wellness LTD. (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO) recently announced a new joint venture partnership with Wake Network, Inc.

September 14, 2022
Revitalist-and-Awakn-Life-Sciences-Announce-Licensing-Partnership-for-Ketamine-Assisted-Therapy-for-Alcohol-Use-Disorder Psychedeic-Chronicle-Logo-White
Psychedelic News

Revitalist and Awakn Life Sciences Announce Licensing Partnership for Ketamine-Assisted Therapy for Alcohol Use Disorder

One of the largest publicly listed ketamine focused clinic operations operating in the United States, Revitalist Lifestyle and Wellness Ltd. (CSE: CALM)

August 15, 2022
Field-Trip-Health-Wellness-Announce-19-Million-Financing-To-Trade-on-TSXV-Under-Ticker-FTHW Psychedeic-Chronicle-Logo-White
Psychedelic News

Field Trip Health & Wellness Announce $19.9 Million Financing, Will Trade on TSXV Under Ticker FTHW

Field Trip Health & Wellness Ltd. announced today that the company has filed the necessary listing application to list its common shares

August 15, 2022
Silo-Pharma-Announce-Topically-Administered-Ketamine-Delivers-Positive-Results-in-Study Psychedeic-Chronicle-Logo-White
Psychedelic News

Silo Pharma Announce Topically Administered Ketamine Delivers Positive Results in Study

Silo Pharma, Inc. (OTCQB: SILO), a development-stage psychedelic biopharmaceutical firm, announced that the company’s patented topically applied ketamine formulation has completed a

August 2, 2022
Ketamine Wellness Centers KWC Launches New Directory of Ketamine Therapists Psychedeic-Chronicle-Logo-White
Psychedelic News

Ketamine Wellness Centers (KWC) Launches New Directory of Ketamine Therapists

The nation’s largest ketamine therapy provider now offers complimentary patient resources supporting holistic mental health treatment. On Thursday, the largest ketamine therapy

July 1, 2022

Recent Posts

  • Choose Ketamine Complete Capital Raise to Expand Technology Platform
  • Biomind Labs Secure FDA Pre-IND Meeting for Feedback on NCE Triptax
  • Silo Pharma Initiate Toxicity Study of Ketamine Formulation for Fibromyalgia Treatment
  • Numinus Develop Psilocybin Mushroom Tea Bags for Psychedelic Research Use
  • atai Life Sciences Announce First Subject Dosed in Synthetic DMT Phase 1 Trial

Recent Comments

No comments to show.

Popular

Choose Ketamine Complete Seed Capital Raise to Expand Technology Platform

Choose Ketamine Complete Capital Raise to Expand Technology Platform

In a major milestone for mental health care, Austin-based Choose

Biomind Labs Secure Pre-IND Meeting, Seek FDA Feedback on New Triptax Depression Treatment

Biomind Labs Secure FDA Pre-IND Meeting for Feedback on NCE Triptax

The well-known psychedelic biotech company Biomind Labs Inc. (NEO: BMND)

Silo Pharma Initiate Toxicity Study of Ketamine Formulation for Fibromyalgia Treatment

Silo Pharma Initiate Toxicity Study of Ketamine Formulation for Fibromyalgia Treatment

Silo Pharma (Nasdaq: SILO), a developmental-stage psychedelic biopharmaceutical firm, announced

Psychedeic-Chronicle-Logo

© 2022 PSYCHEDELIC CHRONICLE
ALL RIGHTS RESERVED.

  • Psychedelic News
  • DMT
  • Ketamine
  • Mescaline
  • Psilocybin
  • CEO INTERVIEWS